This item is in: Biomedicine > Management and business

Outsourcing biopharma R&D to India

P R Chowdhury, J. Sagar Associates, India

Woodhead Publishing Series in Biomedicine No. 2

 - constitutes the first ever comprehensive insight on the Indian biopharma sector
 - provides a perspective based on practical hands-on legal experience
 - simply structured, clearly presented and free from excessive legal jargon
 - a clear understanding of the market is provided

The trend of outsourcing to India for research and development is catching on fast. Over the last decade, worldwide pharmaceutical and biotechnology companies have made India their choice for a research destination. Initially R&D was inclined more towards developing products for the Indian market within the country. This led to several multinational companies opening up production plants in India, primarily due to the globalization of the Indian economy and offshoring jobs to India. Alongside, several global pharma-biotech majors ascertained large market requirements within the country and capitalized on the advantage of serving Indian customers. Strategies were devised to optimize operational expenses with the setting up of on-site R&D to develop products for local requirements. In view of this, this book seeks to explore various nuances of the outsourcing sector with respect to biopharma in India.

ISBN 1 907568 08 5
ISBN-13: 978 1 907568 08 4
May 2011
130 pages  234 x 156mm  hardback  
£125.00 / US$210.00 / €150.00

Usually dispatched within 24 hours

An e-book version of this title is available to purchase as part of a Collection or Pick n Mix or by Chapter. Visit Woodhead Publishing Online

About the author

Probir Roy Chowdhury is Senior Associate of J. Sagar Associates, and is part of the firm's Technology Practice Group. He advises on Information Technology Law in areas including outsourcing, data protection, and e-commerce issues, and his transactional practice includes advice on venture capital fund structuring, transaction structuring, legal due diligence exercises, investment in the education sector, entry strategies and foreign exchange regulations. He writes on several technology-related subjects, and has contributed to the United Nations WSIS Summit project on Technology Surveillance as well as chapters in Advances in Biopharmaceutical Technology in India published by BioPlan Associates Inc. He is a regular contributor to the Computer Law Review International.

Titles which may also be of interest:
Successful biopharmaceutical operations
The application of statistical process control in the pharmaceutical and biotechnology industries
Practical leadership for biopharmaceutical executives

Contents

Biopharma outsourcing in India: its evolution
 - What is outsourcing?
 - What is R&D?
 - Organisational patterns in R&D outsourcing
 - R&D outsourcing in the pharmaceutical industry
 - India as the emerging hub of R&D outsourcing
 - in the pharmaceutical industry
 - Outsourcing models prevalent in India
 - Key issues involved in outsourcing

India’s core competitive advantage in R&D in the biopharma sector: the impetus for outsourcing
 - Introduction
 - Cost competitiveness
 - Resources and skill
 - The role of the government
 - Conclusion

Different modes of outsourcing biopharma R&D to India
 - Indian companies involved in outsourcing activities
 - Contract research services
 - Contract manufacturing organisations
 - Drug substance manufacturing
 - Drug product manufacturing
 - Process development
 - Analytical methods and characterisation
 - Business models for contract manufacturing organisations
 - Insights into outsourcing of product development and manufacture
 - Clinical trials
 - Advantages and disadvantages of doing clinical trials in India
 - Active pharmaceutical ingredient and technology transfer
 - Conclusions and implications

The Indian regulatory environment: a historical perspective
 - Indian Council for Medical Research
 - Central Drugs Standard Control Organisation
 - Department of Biotechnology
 - National Pharmaceutical Pricing Authority
 - Overview of the industry

Implications of the changing regulatory environment in India
 - Introduction
 - Capacity Building Programme: recent development
 - Clinical Trials Registry – India
 - The Indian Society for Clinical Research
 - Conclusion

Creating contracts for outsourcing in the biopharma industry
 - Biopharma outsourcing
 - Preliminary documentation
 - Drafting of the biopharma outsourcing agreement
 - Specific considerations in different types of agreements
 - Conclusion

Environmental, health and safety guidelines and biopharma outsourcing: an Indian perspective
 - Introduction
 - The EHS guidelines
 - EHS guidelines and India
 - Challenges faced by Indian companies in EHS compliance
 - Conclusion

Certifications
 - Introduction
 - Certifications
 - Manufacturing licence
 - Good manufacturing practices
 - No-Objection certificate and certificate of origin
 - Certificate of a pharmaceutical product
 - Certifications for clinical trials
 - International regulatory certifications
 - Conclusion

The need for due diligence of service providers
 - Introduction
 - Sources utilised prior to due diligence
 - Areas of due diligence
 - Due diligence process
 - Contents of the due diligence report
 - Conclusion